Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| X4 Pharmaceuticals, Inc | 96,667 | reported | 10 Jun 2024 | tx 6+112,948 |
| Ultragenyx Pharmaceutical Inc. | 66,849 | reported | 24 Jun 2021 | tx 52+258,506−516,392 |
| APPLIED GENETIC TECHNOLOGIES CORP | 0 | reported | 30 Nov 2022 | tx 14+77,000−79,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jun 2024 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 45,000 | 0.00 USD | |
| 13 Jun 2023 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 45,000 | 0.00 USD | |
| 30 Nov 2022 | TENDER | APPLIED GENETIC TECHNOLOGIES CORP | 8,500 | — | |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 12,000 | — | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 10,000 | — | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 10,000 | — | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 25,000 | — | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 14,000 | — | deriv |
| 06 Jun 2022 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 6,667 | 0.00 USD | |
| 30 Nov 2021 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 14,000 | 0.00 USD | deriv |
| 24 Jun 2021 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,145 | 0.00 USD | |
| 24 Jun 2021 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 4,125 | 0.00 USD | deriv |
| 02 Jun 2021 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 6,000 | 9.50 USD | deriv |
| 23 Feb 2021 | GIFT | Ultragenyx Pharmaceutical Inc. | 1,000 | 0.00 USD | |
| 19 Feb 2021 | SALE | Ultragenyx Pharmaceutical Inc. | 7,500 | 149.01 USD | |
| 19 Feb 2021 | EXERCISE | Ultragenyx Pharmaceutical Inc. | 7,500 | 97.85 USD | |
| 19 Feb 2021 | EXERCISE | Ultragenyx Pharmaceutical Inc. | 7,500 | 0.00 USD | deriv |
| 27 Aug 2020 | GIFT | Ultragenyx Pharmaceutical Inc. | 1,000 | 0.00 USD | |
| 21 May 2020 | GIFT | Ultragenyx Pharmaceutical Inc. | 1,000 | 0.00 USD | |
| 16 Dec 2020 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 12,000 | 0.00 USD | deriv |
| 21 Aug 2020 | EXERCISE | Ultragenyx Pharmaceutical Inc. | 5,000 | 58.74 USD | |
| 21 Aug 2020 | SALE | Ultragenyx Pharmaceutical Inc. | 5,000 | 86.57 USD | |
| 21 Aug 2020 | EXERCISE | Ultragenyx Pharmaceutical Inc. | 5,000 | 0.00 USD | deriv |
| 26 Jun 2020 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,550 | 0.00 USD | |
| 26 Jun 2020 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 4,250 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 14 Dec 2018.